Background Human embryonic stem cells can propagate indefinitely in vitro and are able to differentiate into derivatives of all three embryonic germ layers. The excitement surrounding human embryonic stem cells lies largely in their potential to produce specialized cells that can be used for transplant therapies. However, further investigation requires additional cell lines with varying genetic background. Therefore, efforts to derive and establish more human embryonic stem cell lines are highly warranted. Methods Surplus embryos (blastocysts) from donors were used to isolate the inner cell mass by immunosurgery. All cells were cultured continuously on irradiated murine embryonic fibroblasts feed layer and likely human embryonic stem cell colonies were subsequently characterized by cell surface marker staining, karyotyping and teratoma formation. Results Two human embryonic stem cell lines (SYSU-1 and SYSU-2) were established from surplus embryos. The two lines express several pluripotency markers including alkaline phosphatase, SSEA-4, Tra-1-60, Oct-4, Nanog and Rex-1. They remain in undifferentiated state with normal karyotype after prolonged passages and can form embryoid bodies in vitro and teratoma in vivo. Conclusion Two new human embryonic stem cell lines have been established from surplus embryos. They can be used to understand selfrenewal and differentiating mechanisms and provide more choices for regenerative medicine.
uman embryonic stem embryonic stem (ES) cells are pluripotent cells derived from the inner cell mass of blastocyst stage embryos. [1] [2] [3] That ES cells undergo indefinite selfrenewal in vitro and produce derivatives of all three embryonic germ layers in vitro or in vivo make them a highly prized resource in both clinical and research settings. 4, 5 Many more human ES (hES) cell lines have been derived from human blastocysts since the first successful attempt in 1998. These cell lines have become not only an ideal tool for studying human developmental biology in vitro, but also a source for cells of specific lineages for cell replacement therapy and drug discovery purposes. [6] [7] [8] [9] [10] [11] Although numerous hES cell lines have been established, limited availability of these cell lines has become a major bottleneck to the study of molecular mechanisms of selfrenewal and differentiation, and the comparison of cell characteristics for specific applications. 12 Furthermore, the graft rejection problem of the hES based cell replacement therapy also needs to be considered. A realistic approach may be to establish a hES cell bank, which contains sufficient diversity in human leucocyte antigens (HLA) to match HLA profiles of target populations. 13 To meet the increasing demand for characterized hES cell lines, we describe the successful derivation and establishment of two new human ES cell lines from surplus embryos. The cell lines have proliferated continuously for over a year without the appearance of abnormal karyotypes. They express a variety of markers associated with the undifferentiated state of hES cell and can produce derivatives from all three germ layers in vitro and in vivo.
METHODS

Blastocyst culture
Following in vitro fertilization (IVF) treatment, human pronuclear (PN) stage embryos were first cultured to the eight cell stage. At day 3, embryos were graded according to the scale of Gardner et al. 14 After assessment of number of divisions and cell morphology, good quality embryos were reserved for IVF treatment. The surplus embryos donated to this study with informed consent were transferred to droplets of medium G2.3 for further culturing up to the blastocyst stage. Culture medium G-2.3 (Vitrolife, Sweden) was supplemented with 5 mg/ml human serum albumin (Vitrolife) and 1000 U/ml leukaemia inhibitory factor (LIF, Chemicon, USA). The protocols used in this research follow the stem cell guidelines issued by the Ministry of Science and Technology and the Ministry of Health of China and were approved by the Ethics Committee of the Sun Yat-sen University.
After 10 passages, standard medium for hES cells culture was used. The medium comprised of 80% knockout DMEM supplemented with 20% knockout serum replacement, 2 mmol/L L-glutamine, 0.1 mmol/L β-mercaptoethanol, 1% nonessential amino acids, 100 U/ml penicillin, 100 µg /ml streptomycin, 1000 U/ml recombinant human leukaemia, inhibitory factor and basic fibroblast growth factor (bFGF, 4 ng/ml).
Preparation of feeder layer
Mouse embryonic feeder cells (MEF, Cyagen Biosciences, USA) were isolated from 13-14 dpc of KM strain mice and cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco Invitrogen, USA); supplemented with 2 mmol/L glutamine, 0.1 mmol/L β-mercaptoethanol and 1% nonessential amino acid (Sigma, USA); 10% foetal calf serum (HyClone, USA). Within 5 passages, the MEF cells were treated with 55 Gy γ-ray irradiation and washed by phosphate buffered saline (PBS) five times before transference to dishes treated with 0.1% gelatin coated, tissue culture of suitable density.
Isolation and primary culture of inner cell mass
Inner cell mass (ICM) was isolated from blastocysts by immunosurgery. 15 In brief, zona pellucida was treated with 0.5% pronase (Sigma, USA) for 1-2 minutes at 37˚C in 5% CO 2 atmosphere. Then zona free, blastocysts were incubated in DMEM containing rabbit antihuman serum (Sigma, USA) diluted 1:10 for 30 minutes at 37˚C, followed by an additional 30 minutes treatment in 1:5 dilution of guinea pig complement (Sigma) at 37˚C in 5% CO 2 . Lysed trophectoderm cells were removed by gently pipetting and the ICMs were isolated from trophectoderm.
The intact ICMs were plated immediately onto γ-ray irradiated and inactivated mouse embryonic fibroblast feeder layer in gelatin coated tissue culture dishes containing hES cell culture medium (80% knockout DMEM, supplemented with 15% knockout serum replacement, 1% nonessential amino acids, 8 ng/ml human basic fibroblast growth factor (bFGF, Gibco Invitrogen); 5% foetal bovine serum (HyClone, USA); 0.1 mmol/L β-mercaptoethanol, 100 U/ml penicillin and 100 µg/ml streptomycin (Sigma); 1000 U/ml recombinant human leukaemia inhibitory factor (hLIF, Chemicon)).
Total RNA was extracted from hES cells cultured on MEFs, or from control MEFs with Trizol reagent (Invitrogen) according to the vendor's protocol. DNase I was used to eliminate genomic DNA contamination and ensure that the PCR product represented the specific mRNA species. cDNA were produced by reverse transcription reaction with 500 ng of total RNA using oligo(dT)
Culture of hES cells
Eight to ten days after initial plating, the ICM cell clumps that resembled stem cells were mechanically dispersed from differentiated cell outgrowths using a micropipette, placed on a fresh feeder layer and cultured under the same conditions as described above. Every seven or eight days, colonies were propagated using mechanical dissociation, or collagenase IV (1 mg/ml, Gibco Invitrogen). Culture media were changed every day. Colonies were also periodically selected by mechanical dissociation and cryopreserved in liquid nitrogen with the frozen medium containing 90% FBS/10% DMSO (Sigma).
Alkaline phosphatase activity assay
The activity of alkaline phosphatase was assessed by histochemical staining. Human ES cells were fixed in 4% paraformaldehyde at room temperature for 15 minutes, washed twice with PBS, stained with BCIP/NBT (Maxim Biotech Inc.) for 20-30 minutes and detected for colour reaction by light microscopy. Human ES cells stained for alkaline phosphatase activity, but colonies spontaneously differentiated and feeder layers did not.
Immunocytochemistry analysis
To detect the expression of SSEA-1, SSEA-4, TRA-1-60, and Oct-4, hES cells were processed for immunocytochemistry using standard protocol from vendor's instructions. Briefly, undifferentiated hES cells grown on a layer of mouse embryonic fibroblasts were fixed within 4% paraformaldehyde, and incubated with primary monoclonal antibodies at appropriate dilution at 4˚C. Then the cells were treated with fluorescent conjugated secondary antibody diluted at 1 : 500 (v/v) (Cy3 Jackson Immuno Research, USA). SSEA-1 and SSEA-4 were supplied by the Developmental Studies Hybridoma Bank, University of Iowa, USA; TRA-1-60 and Oct-4 were supplied by Chemicon. [12] [13] [14] [15] [16] [17] [18] as primers (Invitrogen) and Moloney murine leukaemia virus reverse transcriptase (Invitrogen). cDNA samples were amplified by PCR with DNA primers selective for the human genes. The PCR reaction was carried out in a volume of 10 µl containing 2 µl of cDNA template, 2.5 mmol/L MgCl 2 , 200 µmol/L of each deoxynucleotide triphosphate, 200 nmol/L of each primer, 0.05 U Taq DNA polymerase (Fermentas, USA), and 1× PCR reaction buffer. The sequences of the primer were as following: Oct4 (forward, cgtgaagctggagaaggagaagctg; reverse, caagggccgcagcttacacatgttc), Rex1 (forward, ctgaagaaacgggcaaagac; reverse, gaacattcaaggg-agcttgc), and Nanog (forward, caaaggcaaacaacccactt; reverse, ctggatgttctgggtctggt) (Invitrogen). β-actin (200 bp) was used as positive control. PCR started with an initial denaturation at 95˚C for 10 minutes, followed by 38 amplification cycles (94˚C for 45 seconds, 56˚C for 45 seconds, and 72˚C for 45 seconds), followed by 7 minutes at 72˚C. The PCR products were electrophoresed on 1.5% agarose gels stained with ethidium bromide.
Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis
Karyotype analysis
For chromosome analysis, hES cells in the exponential growth stage were treated for 2 hours with colcemid (0.1 µg/ml). After colcemid treatment, digested single cells were karyotyped using G-band method.
In vitro differentiation
To induce the formation of EBs, undifferentiated hES cell colonies in 6-well plates were digested with trypsin/EDTA, then transferred to nonadhesive plastic petri dishes to allow aggregation and prevent adherence to the plate. The EBs were cultured in EB medium consisting of 85% knockout DMEM supplemented with 15% knockout serum replacement, 2 mmol/L L-glutamine, 0.1 mmol/L β-mercaptoethanol and 1% nonessential amino acids. The medium was changed every day.
For the detection of differentiated derivatives by immunocytochemistry, EBs (day 7) were plated on 0.2% gelatin coated 6-well plates, grown in DMEM containing 10% FBS to induce further differentiation for 14 days and fixed in 4% paraformaldehyde followed by fluorescent immunostaining. The following antibodies were used: microtubule associated protein 2 and α-smooth muscle actin (Sigma) and albumin (Dako).
Teratoma formation in nude mice
During routine passage, the colonies were digested with trypsin EDTA solution for 1 to 3 minutes, and dissociated into clumps of 50 to 100 cells. These clumps were collected and injected subcutaneously into the hind leg of four to five-week old nude mice (two or more mice per cell line). Six weeks after transplantation, the teratoma became apparent and was removed, fixed for 4-8 hours in 4% paraformaldehyde, embedded in paraffin and cut in 10 µm sections. After staining with haematoxylin and eosin, the sections were observed under light microscope.
RESULTS
Derivation and culture of hES cells
During this study, fifty surplus embryos were collected. Twenty embryos developed into blastocyst stage with normal size ICM when cultured in G2.3 medium for 6-7 days (Fig. 1A) . The zona pellucida was removed from blastocyst stage embryos by 0.5% pronase if the embryos did not detach from zona by themselves. After trophoblast cells were lysed by immunosurgery, inner cell masses were plated on irradiation inactivated MEFs. Within 24 hours, isolated inner cell masses adhered to the well surface and fourteen inner cell masses grew to form initial colonies (Fig. 1B-C) . Eight to ten days later, the initial colonies grew and spread on the feeder. Then the growing colonies were manually separated into a few clumps and transferred to a fresh well. Two initial colonies expanded and grew into stem cell like cells that displayed stable growth and morphology similar to that of human ES cells. They were designated as SYSU-1 and SYSU-2. (Fig. 1D-G) The ES cells were observed under a phase contrast microscope where all showed typical morphological characteristics of hES cells, including flat round or elliptic colonies with clear edges and a high nucleus to cytoplasm ratio for single cells (Fig. 1E, G) .
During the early passages, the colonies were separated from the outer, surrounding feeder layer and mechanically cut into small clumps before being placed onto fresh feeder layers. By this method, undifferentiated hES cells could be efficiently separated from differentiated cells. However, mechanical manipulation is a relatively cumbersome process and time consuming. After passage ten, routine cultures were passaged by collagenase treatment except for the maintenance of hES cell lines.
Characterization of two human embryonic stem cell lines
We examined the two cell lines, by immunocytochemistry and RT-PCR, for the expression of cell surface markers and genes that were characteristic of the undifferentiated state. Neither line expressed SSEA-1, but both expressed SSEA-4, TRA-1-60, and Oct-4 (Fig. 2) . They also showed a high level of alkaline phosphatase activity (Fig.  2) . In addition, they revealed expression of Nanog, Rex1 and Oct-4 by RT-PCR analysis (Fig. 3) .
Karyotype analysis of the hES cells
Karyotype analysis of the two cell lines were performed by Giemsa banding. One was analyzed and showed a normal 46XX karyotype on passages 26 (6 months in culture) (Fig. 4A) . The other was examined at passage 18 and showed a normal 46XX karyotype (Fig. 4B) .
In vitro differentiation
Similar to other hES cell lines, SYSU-1 and SYSU-2 formed EBs in vitro (Fig. 5A-B) .
After 7 days of culture in suspension, EBs were attached to gelatin coated, plastic dishes for 14 days where they differentiated into various types of cells that expressed tissue specific markers, such as albumin (Fig. 5C-F) , MAP2 (Fig. 5G-J) and α-SMA (Fig. 5K-N) . This demonstrates that these cells can form tissues that are derivatives of endoderm, ectoderm and mesoderm.
In vivo differentiation
For examining their in vivo differentiation potentials, the two cell lines were transplanted into nude mice to test teratoma formation. When clumps of two hES cell lines were injected subcutaneously into four to five weeks old SYSU-1 (passage 5). F-G: Colony of human ES cell line SYSU-2 (passage 5), all colonies are flat with clear edges. (E) and (G) higher magnification of ES colonies show a high ratio of nucleus to cytoplasm. Scale bars: 100 µm. nude mice, the SYSU-2 ES cell line formed teratomas after 6 weeks. Histological examination revealed that these teratomas contained tissues of three embryonic germ layers: ectoderm (primitive neuroepithelial tubule Fig. 6B ), endoderm (glands Fig. 6C ), and mesoderm (cartilage Fig. 6A and fat like cells Fig. 6D) . However, the SYSU-1 ES cell line did not produce teratomas under such condition. Interestingly, teratoma developed from the SYSU-1 ES cells when cultured on the feeder layers derived from human foetal mesenchymal stem cells (unpublished 
DISCUSSION
Most embryos used to establish hES cell lines are leftovers from clinical in vitro fertilization (IVF) treatment. It has been reported that blastocysts from surplus embryos have poorer morphology compared with blastocysts from good quality embryos. 16 The poor quality of embryos such as the presence of nucleate fragments and irregular blastomeres, the lack of a distinct inner cell mass (ICM) or the shortage of cells within the ICM may adversely affect the success rate of the hES cell line derivation.
In our study, surplus embryos were collected only after high quality ones had been transferred into patients on day 2 or 3 after fertilization. Some of the surplus embryos developed poorly from day 3. Fifty embryos were collected and cultured in G2.3 medium into which 1000 U/mL hLIF was added. Blastocysts were obtained from about 50% of the embryos. Fourteen initial colonies were isolated. Finally, two hES cell lines were derived.
Leukaemia inhibitory factor (LIF) is thought to play an important role during the development of embryos. 17, 18 Cheng et al 17 found that when LIF antisense oligonucleotide was added to two pronuclear stage embryos, development was arrested at morula stage or blastocyst stage. However, blastocysts cultured with LIF had higher rates of formation than those in the LIF gene impaired group without LIF treatment. 17 In our study, some of ICMs isolated from immunosurgery did not attach to plate. Several studies had demonstrated that hES cells could be maintained in serum replacement containing medium supplemented with 36-40 ng/ml bFGF. In early passage culture, 8 ng/ml bFGF and 8% serum were added to the medium to enhance the adherence of ICM cells from blastocyst stage. Our results indicate that bFGF may enhance the efficiency of formation of initial colonies by promoting the expression of extracellular matrix (ECM) molecules through the activation of the PI3K/Akt/PKB pathway. 22 However, the mechanism of bFGF activity needs further investigation.
In this research, two new human ES cell lines were derived from embryos. The two cell lines exhibited characteristic typical of hES cell, including hES cell morphology, the expression of the surface markers (SSEA-4, TRA-1-60) and the expression of specific transcription factors: Oct4, Nanog and Rex-1. They both showed normal diploid karyotype up to the 26th passage and could form EBs in suspension culture. They both developed teratomas in vivo, although cultured under different conditions.
In conclusion, two new human ES cell lines have been established from surplus embryos. They can be used to understand the selfrenewal and differentiation mechanisms and provide more choices for regenerative medicine.
